Rationale and design of Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY): A multicenter randomized trial
BACKGROUND: Shuxuening injection (SXNI), a multi-target cerebroprotectant, holds promise as adjuvant therapy to intravenous thrombolysis (IVT) in acute ischemic stroke (AIS), but its efficacy has not yet been established. AIM: The aim of this study was to present the rationale and design of the Shux...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| Серии: | Brain Circulation |
| Предметы: | |
| Online-ссылка: | https://journals.lww.com/10.4103/bc.bc_65_25 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|